First Tracks Biotherapeutics Announces $200 Million Private Placement
Bitget2026/10/15 12:09- First Tracks Biotherapeutics agreed to sell 6,106,870 shares of common stock at $32.75 per share in a private placement.
- Expected gross proceeds total approximately $200 million before placement agent fees and other expenses.
- Closing is expected on October 19, 2026, subject to customary closing conditions.
- Proceeds will fund general corporate purposes, including clinical development of ANB033, a CD122 antagonist.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Foreign holdings of US Treasuries rebounded in August, with UK holdings surpassing $1 trillion for the first time
In August, foreign holdings of U.S. Treasury bonds increased by over 83 billions USD, with Canada and Belgium leading the increase; meanwhile, holdings by Japan and China continued to decline to multi-year lows, and for the first time, the UK's holdings surpassed 1 trillion USD.
Strive's bitcoin holdings increased to 35,595, and TD Cowen raised its target price to $56.
New York Federal Reserve Survey: Service Sector Price Increases Hit Fastest Pace Since 2022, Business Activity Index Drops to Lowest Since March
A survey released by the New York Fed on Friday shows that in October, sales prices for service sector firms increased at the fastest pace since 2022, with input costs remaining robust and supply conditions continuing to deteriorate. Businesses’ pessimism about the commercial outlook has significantly intensified, with the overall business activity index falling by 12 points from the previous month to minus 20.7, marking the weakest reading since March.
Raoul Pal Holds Bitcoin, Solana and Ethereum, but Calls One Wildly Undervalued
Crypto prices
More
